This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine are also expected to have shorter duration of supplemental oxygen requirement, fewer episodes of oxygen desaturation, improved pulmonary toilet, lower use of antiemetics, and shorter times to first bowel movement. Ketamine is further expected to be associated with decreased intensive care unit and hospital lengths of stay, faster time to maximum allowable ambulation, decreased opioid dosage at discharge, and lower report of chronic pain syndromes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
20
Ketamine administered as patient-controlled analgesia.
Hydromorphone administered as patient-controlled analgesia.
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Total Daily Opioid Requirement
Daily breakthrough opioid requirement plus non-breakthrough opioid use in milligrams of morphine equivalents
Time frame: Participants will be followed for their entire hospital stay, an expected average of 1 week.
Breakthrough Daily Opioid Requirement
Breakthrough daily opioid requirement in milligrams of morphine equivalents/day
Time frame: Participants will be followed for their entire hospital stay, an expected average of 1 week
Median Pain Score
Median daily pain score measures on a visual analogue scale for pain, with a range of 0 to 10. Higher scored indicate worse pain.
Time frame: Participants will be followed for their entire hospital stay, an expected average of 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.